Texte à méditer :  
Le travail éloigne de nous trois grands maux : l'ennui, le vice et le besoin.   Voltaire (Candide)

Google Traducteur

Fermer Annonces

Fermer Annuaire

Fermer Bureau et Membres

Fermer Liens

Fermer Statuts


Fermer Etudiants

Fermer Résidents

Fermer Activités de la SATOX

Fermer Activités scientifiques

Fermer Biblio

Fermer Resources Externes

Vidéo test Vidéos Journées Nationales Vidéos-Congrès


Propositions d'Articles

Désolé, mais seul les membres de ce site peuvent proposer :

Un article
Une nouvelle
Un téléchargement
Un lien
Un lien RSS
Un message dans l'agenda

Voir les propositions en attentes

Bulletins Alerte Méd

fermer Matériovigilance

Activités Scient.

fermer Congrès-Symposiums

Activités membres
Revues ToxAlgérie
ToxAlgérie N°1  

ToxAlgérie N°2  

ToxAlgérie N°3
news.gifArticles - - MedIndia

Latest Drug Toxicity News

Medindia largest health website in india.

New Drug Combination for High-Risk Neuroblastoma  Voir?

bHighlights:/b ul class = "group-list punch-points" liA new drug-combination for the treatment of high-risk neuroblastoma has been identified. /li liThe combination is made of epigenetic inhibitors and B-cell lymphoma 2 (BCL-2) inhibitors. /li liBCL-2 inhibitors are already approved by the U.S. Food and Drug Administration. /li/ul A promising target to reverse the development of high-risk neuroblastoma and potential new drug combination for novel therapy have been identified ...

... / ... Lire la suite

Link Between Estradiol and Anxiety during Drug Withdrawal  Voir?

Estradiol (ovarian hormone) may make drug withdrawal symptoms worse for women, reveals a new study. The findings of the study are published in the journal iNeuroscience Letters /i. New research suggests women may have more difficulty than men in withdrawing from and staying off methamphetamine. The study by Dickinson College neuroscientists looked at the interaction of estradiol--a naturally occurring form of estrogen and the major female sex hormone--and methamphetamine in female mice. Researchers ...

... / ... Lire la suite

Opioid Pain Medications Increase Risk of Bone Fractures, Delay Fracture Healing  Voir?

Opioid use, which includes chronic overuse of certain medications, may increase the risk of bone fractures and also affects the fracture repair process. Dr. Robert Zura, Professor and Chair of Orthopaedic Surgery at LSU Health New Orleans School of Medicine, was part of a research team reporting the serious effects of chronic overuse of certain medications in fracture healing. The authors also question their effectiveness in controlling pain. Dr. Zura is a coauthor of the 'Article in Press' available online in the journal, iInjury/i....

... / ... Lire la suite

What is The Best Drug Combination for Ankylosing Spondylitis?  Voir?

Among patients with ankylosing spondylitis, a combination of two drugs - non-steroidal anti-inflammatory drugs (NSAIDs) and tumor necrosis factor (TNF) may result in an optimal reduction of radiographic progression. When looking at specific NSAIDs, celecoxib in combination with TNF inhibitor use was associated with the greatest reduction in radiographic progression, which was significant at both two and four years. "bOur results suggest that the use of TNF inhibitors and NSAIDs, particularly ...

... / ... Lire la suite

Oral Antifungal Drug Fluconazole Not Linked With Stillbirth Risk  Voir?

The use of fluconazole was not associated with increased risk of stillbirth or neonatal death, and the results were similar for different drug doses, stated study from a Swedish and Norwegian team of researchers led from Karolinska Institutet and published in JAMA. Vaginal candidiasis is common in pregnancy. Intravaginal formulations of topical antifungal drugs are first-line treatment for the infection, but oral antifungal drugs - typically fluconazole - are used in cases with severe symptoms, ...

... / ... Lire la suite

New Treatment for Drug Addiction Relapse Identified  Voir?

A new mechanism has been developed for combatting drug addiction relapse by scientists at the University of Bath and the study was published in iAddiction Biology/i. Relapsing into drug taking is a big problem in treating addiction, where the majority of addicts return to drug-taking within 12 months of quitting. This is brought into focus by the burgeoning 'opioid epidemic' of prescription as well as recreational opioid drugs, such as morphine and heroin. bAddiction relapse/b is ...

... / ... Lire la suite

Novel Epigenetic Drug Found Effective Against Mantle Cell Lymphoma  Voir?

New compound with epigenetic and anti-tumor effects was found to be effective against Mantle Cell Lymphoma (MCL). It is a type of cancer characterized by its aggressive behavior, its delayed diagnosis with affectation of different organs and its origin from the lymphocytes B. The study was carried out by doctor Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona....

... / ... Lire la suite

Drug Impairs Cancer Cell Growth and Survival  Voir?

Pre-clinical results for IACS-10759 drug lead to Phase I clinical trials in acute myeloid leukemia and solid tumors, revealed two papers published in Nature Medicine. The drug IACS-10759 was discovered and advanced by The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science (IACS) and the Center for Co-Clinical Trials. IACS-10759 is the first small molecule drug to be developed from concept to clinical trial by MD Anderson's Therapeutics Discovery team, which includes IACS and the CCCT....

... / ... Lire la suite

Double-checking Diabetes Medications Can Improve Patient Outcomes, Reduce Re-hospitalizations  Voir?

Medication reconciliation can improve health outcomes and reduce re-hospitalizations in diabetes patients, reports a new study. The findings of the study are published in the iDiabetes Care/i journal. Clinicians may take upwards of 15 minutes to double-check a patient's medication list in an electronic health record system, but according to a new study, this reconciliation process may be well worth the time for diabetes patients. Brigham and Women's Hospital physician Alexander Turchin, MD, ...

... / ... Lire la suite

Barriers That Prevent HIV Patients Access to Lifesaving Drug  Voir?

There are multiple barriers that may stop high-risk individuals from accessing a HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study. The study is published in the journal iAIDS and Behavior/i. Researchers outlined solutions that would help overcome barriers that make it harder for underserved populations to access pre-exposure prophylaxis (PrEP). The Centers for Disease Control and Prevention reported that nearly 40,000 people--about ...

... / ... Lire la suite

New Drug Reduces Risk of SIRS and Sepsis  Voir?

bDrug deformylase/b may one day be a new treatment option for patients with systemic inflammatory response syndrome, or SIRS, a body-wide inflammatory reaction to trauma or infection, as well as sepsis, a systemic infection when the cause of the infection, like a bacteria, is known, report researchers at the Medical College of Georgia at Augusta University. "We are hoping our work will improve the care of trauma and other critically ill patients," says Dr. Patricia Martinez Quinones, general surgery resident at MCG and AU Health....

... / ... Lire la suite

Deformylase - A Potential New Drug For Sepsis  Voir?

bDeformylase/b, a new drug, may be able to bsuppress the response of the immune system to infection that can harm the body/b, claims a research team at the Medical College of Georgia at Augusta University. When trauma spills the contents of our cell powerhouses - mitochondria, it can evoke a potentially deadly immune response much like a severe bacterial infection. A drug that cleaves escaped proteins called N-formyl peptides appears to reduce resulting dangerous leakage from blood vessels and improve survival....

... / ... Lire la suite

Asthma Drug Reverses Cognitive Impairments in Mice With Dementia  Voir?

In an animal model, tau pathology - the second-most important lesion in the brain in patients with Alzheimer's disease was reversed using zileuton drug, stated Lewis Katz School of Medicine at Temple University (LKSOM) researchers. Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. "We ...

... / ... Lire la suite

New Insights into Drug Addiction  Voir?

Human drug addiction behaviors are tied to specific impairments in 6 brain networks, revealed a systematic review of more than 100 published neuroimaging studies by experts at the Icahn School of Medicine at Mount Sinai and published in the journal Neuron. Drug addiction is a disorder that encompasses not only excessive drug-seeking and taking, but also fundamental changes in cognition and emotional processing. It comprises core clinical symptoms and behavioral manifestations including ...

... / ... Lire la suite

Drug That Reduces Delirium in Postoperative Patients may Lead to Better Care: Study  Voir?

Drug that reduces delirium in older patients after surgery may work by preventing the overactivity of certain receptors in brain cells, reports a new study. The findings of the study are published in iAnesthesiology/i. The research team says the findings could lead to the more widespread use of the drug, dexmedetomidine, and speed the development of new treatments for postoperative delirium with fewer side effects. Dexmedetomidine is used after surgery and in the intensive care unit (ICU) ...

... / ... Lire la suite

After a Miscarriage: New Drug Combination Could Help Ease the Pain  Voir?

A drug combination containing mifepristone and misoprostol can help ease the physical pain of women who have suffered a miscarriage. This drug combination could complete the process of expelling pregnancy tissue on its own less painful after a miscarriage. The findings of this study are published in the iNew England Journal of Medicine/i. Results of a new clinical trial led by researchers at the Perelman School of Medicine at the University of Pennsylvania show that while the standard drug ...

... / ... Lire la suite

Novel Nuclear Medicine Method Effectively Detects Neuroendocrine Tumors  Voir?

New radiolabeled tracer 68Ga-OPS202 was found to better detect neuroendocrine tumors than current methods, stated study featured in the June issue of The Journal of Nuclear Medicine. Neuroendocrine tumors (NETs) can occur in almost any organ, but they are most commonly observed in the pancreas and gastrointestinal tract. The average time until diagnosis is 3 to 10 years. An estimated 40 to 95 percent of cancerous gastroenteropancreatic NETs (GEP-NETs) have spread to other parts of the body (metastasized) by the time of diagnosis....

... / ... Lire la suite

Resistant Cancer Can Now Be Re-Sensitized To Cancer Drugs  Voir?

Resistant cancer cells can be prone to treatment again, if the growth of their 'antennae' like structure is stopped, finds a new study. The findings of this study are published in the journal of ICell Reports/I. Their study found that drug-resistant cancer cells have more and longer antennae than those which are killed by treatment. Blocking the growth of antennae reactivated a range of cancer treatments that had stopped working, the team at The Institute of Cancer Research, London, found....

... / ... Lire la suite

For Head And Neck Cancer - Two Drugs May Be Better Than One  Voir?

bA combination of drugs to enhance therapeutic effect for head and neck cancer has been identified/b by a research team at the University of Colorado Anschutz Medical Campus. The five-year survival rate for locally-advanced a href="https:www.medindia.net/patients/patientinfo/head-and-neck-cancers.htm?utm_source=medindia (and) utm_medium=widget (and) utm_content= (and) utm_campaign=news-link" target="_blank" class="vcontentshlink" alt="Head and Neck Cancers" title="Head and Neck Cancers"head and neck cancer/a ...

... / ... Lire la suite

Arthritis Drugs May Impact Mental Health  Voir?

Arthritis drugs may impact mental health by improving pain and stiffness and by targeting inflammatory processes common to arthritis and depression, reports a new study. The findings of the study are published in iArthritis (and) Rheumatology/i. However, a recent review of published studies demonstrates that relying on rheumatoid arthritis therapies alone may not meaningfully improve patients' mental health. The findings indicate that providing dedicated mental health care is essential to ...

... / ... Lire la suite

Experimental Drug Improves Bladder Function After Spinal Cord Injury  Voir?

A new experimental drug could one day restore bladder function after spinal cord injury, dramatically improving the quality of life of patients, according to a new study published in iThe Journal of Clinical Investigation/i. Researchers at The Ohio State University tested the drug - which is currently available only for research - to gauge its potential to improve bladder function after a href="http://www.medindia.net https:www.medindia.net/patientinfo/spinal-cord-injury.htm?utm_source=medindia (and) utm_medium=widget (and) utm_content= (and) utm_campaign=news-link ...

... / ... Lire la suite

Protein Inhibitor Drug Benefits AML Patients  Voir?

In a study of patients with acute myeloid leukemia (AML) with relapsed or refractory disease, ivosidenib, an experimental drug known to inhibit a protein often mutated in several cancers was found to be safe, resulting in durable remissions. The multi-center Phase I trial, led by researchers at The University of Texas MD Anderson Cancer Center, was designed to determine ivosidenib's safety and efficacy in treatment of patients with a form of AML in which the enzyme isocitrate dehydrogenase 1 (IDH1) is mutated....

... / ... Lire la suite

How Lipid Molecules Help Cancer Grow and Resist Cancer Drugs  Voir?

When the blood supply is low cancer cells use lipid molecules as fuel instead of blood glucose to grow. This mechanism has been shown in animal tumor models by researchers at Karolinska Institutet in Sweden in a study published in iCell Metabolism. /i The process may help explain why tumors often develop resistance to cancer drugs that inhibit the formation of blood vessels. Tumor growth and spread rely on angiogenesis, a process of growing new blood vessels that supply the cancer cells with ...

... / ... Lire la suite

Ibrutinib - Leukemia Drug may be Effective in Brain Tumor  Voir?

bIbrutinib/b, an FDA-approved drug for lymphoma and leukemia, may improve survival rates in bglioblastoma/b, a type of brain cancer. The team of researchers, led by Shideng Bao, Ph.D., of Cleveland Clinic's Lerner Research Institute found that ibrutinib slowed brain tumor growth in a preclinical model and extended survival more than 10-times the rate of the current standard-of-care chemotherapy drug. They found in human a href="https:www.medindia.net/glossary/glioblastoma.htm?utm_source=medindia (and) utm_medium=widget (and) utm_content= (and) utm_campaign=news-link" ...

... / ... Lire la suite

Combo Drug of NSAID and Soy Lecithin can Combat Cancer  Voir?

Lecithin, a chemical found in soybeans when added to a non-steroidal anti-inflammatory drug (NSAID), increased its anticancer properties and reduced its side effects, finds a study by scientists at The University of Texas Health Science Center at Houston (UTHealth). The findings of the preclinical study appear in the journal iOncology Letters/i. "The results support the potential use of NSAIDs associated with phosphatidylcholine for the prevention and treatment of colorectal cancer," said Lenard Lichtenberger, Ph....

... / ... Lire la suite

Combination Drug Could Fight Cancer  Voir?

A new approach has been introduced wherein two synergistic drug components are combined into a dimer in high concentrations for efficient cancer therapy with few side effects, according to novel research. The finding of the study was published in the journal iAngewandte Chemie/i. This dimer can be incorporated into polymeric nanotransporters at exceptionally high concentration. The components are activated when the dimer is split within the tumor. In addition, they enable use of two different imaging techniques....

... / ... Lire la suite

First Human Trials Of Alzheimer's Drug  Voir?

UK is set to launch the first human trials of ground-breaking drug shown to repair DNA damage that contributes to Alzheimer's disease, reported sources. The study, also being launched this week in hospitals in France and Spain, will see the neuro-degenerative condition treated with an agent which acts as a DNA repair kit to restore memory and reverse behavioural changes such as aggression and social avoidance, the express.co.uk reported late on Sunday. The drug, known as ORY-2001, contains ...

... / ... Lire la suite

Prescribed Medication Along With PCI Better Treatment for Heart Disease Patients  Voir?

People with common heart disease are most often treated with just medication, however a non-surgical procedure, called percutaneous coronary intervention (PCI), along with prescribed medication is best recommended for such patients, suggest an international clinical trial co-led by St. Michael's Hospital. Published today in the iNew England Journal of Medicine/i and simultaneously presented at EuroPCR 2018 in Paris, France, the five-year analysis of the FAME 2 trial shows that initial PCI along ...

... / ... Lire la suite

Drugs Used to Treat Parkinson's may Work for TB too  Voir?

A molecular mechanism has been discovered explaining genetic evidence linking LRRK2 to mycobacterial diseases. An LRRK2 (and) #8208;dependent cellular pathway has been identified that controls M. tuberculosis replication by regulating phagosome maturation. The findings of this study are published in the journal of IEMBO Journal/I. The findings, which will be published in The EMBO Journal, provide a possible explanation of the cause of Parkinson's disease and suggest that drugs designed to treat Parkinson's might work for TB too....

... / ... Lire la suite

A Cancer Patient's Remarkable Response to Antimalarial Drug Treatment  Voir?

An ovarian cancer patient's exceptionable journey to recovery could be attributed an antimalarial drug treatment she received for an autoimmune disease, according to a case report. The report which discusses in detail the patient's remarkable recovery and response to treatment was published in iecancermedicalscience/i. Researchers led by Dr Franco Muggia, Professor of Medicine at NYU Langone's Perlmutter Cancer Center, New York, USA, describe a case of a patient who received treatment for dermatomyositis, ...

... / ... Lire la suite

Eczema Drug 'Dupilumab' can relieve Asthma Symptoms  Voir?

bHighlights:/bul class="group-list punch-points"liDupilumab was able to relieve symptoms in moderate to severe asthma./liliIt has been approved by the FDA to treat eczema./liliIt was found to alleviate asthma symptoms better than the standard therapies./li/ul Dupilumab, an FDA approved eczema drug was surprisingly found to relieve severe asthma attacks, finds a new study. Two new studies have shown that the eczema drug can, in fact, relieve symptoms in difficult-to-control asthma cases....

... / ... Lire la suite

Drug for Blood Disorder can be Used to Treat Breast Cancer  Voir?

An FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer. The findings are published in the iJournal of Clinical Investigation/i by a research team at Mayo Clinic. In this study, Mayo investigators identified that the drug 5-aza-2'-deoxycytidine (decitabine) which is FDA approved for the treatment of certain hematological (blood) cancers, could significantly inhibit the growth of triple-negative a href="http://www.medindia.net https:www....

... / ... Lire la suite

Planning a Trip to Mars? You may Want to Remember Your Anti-radiation Pills  Voir?

New study has identified the first potential treatment for the brain damage caused by exposure to cosmic rays in outer space. The drug developed in the lab of UCSF neuroscientist Susanna Rosi, PhD, prevents memory impairment in mice exposed to simulated space radiation. The study was published in iScientific Reports/i. a href="http://www.medindia.net https:www.medindia.net/news/healthinfocus/excited-nasa-revolutionary-drug-to-reverse-aging-168816-1.htm?utm_source=medindia (and) utm_medium=widget (and) utm_content= (and) utm_campaign=news-link ...

... / ... Lire la suite

Pregnancy Drug DES Triggers ADHD Generations Later  Voir?

Elevated odds for attention deficit hyperactivity disorder (ADHD) in the grandchildren of users of diethylstilbestrol, a synthetic estrogen commonly known as DES prescribed between 1938 and 1971 to prevent pregnancy complications, found study conducted by researchers at Columbia University's Mailman School of Public Health and Harvard T.H. Chan School of Public Health. The findings are published online in JAMA Pediatrics. DES treatment for pregnant women was phased out after a 1953 study showed ...

... / ... Lire la suite

First Drug to Prevent Chronic Migraines Developed  Voir?

bHighlights/b ul class = "group-list punch-points" liFirst drug to prevent chronic migraines has been approved by the U.S. Food and Drug Administration (FDA)/li liAimovig is the first new drug that helps treat migraines in adults with episodic or chronic migraines/li liThe drug is administered through monthly self-injections, requires a prescription and can be available to patients within a week/li/ul The first drug to prevent chronic migraines has been developed and approved by the U....

... / ... Lire la suite

Drug Abuse may Really Set In If Kids Start Smoking Pot Before 15  Voir?

Young men who had started smoking pot before the age of 15 are more likely to develop drug abuse problems by the age of 28, finds a new study. The findings of this study are published in the ICanadian Journal of Psychiatry/I. The study suggested that bboys who start smoking pot before the age of 15 are much more likely to have a drug problem at 28 than those who start at 15 or after/b. According to the researchers, in these teens, the risk of having a drug abuse problem by age 28 is 68 percent....

... / ... Lire la suite

Old Drug Shows Promise for Treatment of Motor Neurone Disease  Voir?

Ebselen, a drug which was discovered in the 1980s and has been investigated as a potential treatment for a variety of nervous system disorders, can effectively restore several important steps in the SOD1 assembly process including folding, dimerization and zinc binding, found biochemists at the University of Liverpool. MND is an incurable, progressive disease that attacks the nerves controlling movement so muscles no longer work. MND affects about 5000 people in the UK at any one time and ...

... / ... Lire la suite

New Drug Therapy to Stop Cancer Spread Developed  Voir?

A compound that blocks the spread of pancreatic and other cancers in various animal models has been identified by a team of researchers at the National Institutes of Health, Northwestern University and their collaborative research partners. When cancer spreads from one part of the body to another in a process called metastasis, it can eventually grow beyond the reach of effective therapies. Now, there is a new plan of attack against this deadly process, thanks to the team of scientists. The team ...

... / ... Lire la suite

Ovarian Cancer Drug Rucaparib Can Treat Pancreatic Cancer Patients With BRCA Mutation  Voir?

Patients with aggressive pancreatic cancer with BRCA1 and BRCA2 mutations who have few or no other treatment options can benefit from rucaparib drug. In a previous targeted therapy rucaparib has shown its power in fighting ovarian cancer in women including those who harbor these mutations. An international team of researchers led by the Perelman School of Medicine and the Basser Center for BRCA at the University of Pennsylvania reported their findings in iJCO Precision Oncology/i. The drug, ...

... / ... Lire la suite

Psoriasis Patients Taking Humira Drug Show No Change in Aortic Vascular Inflammation  Voir?

Drug adalimumab - marketed as Humira used to treat psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation - a key marker of future risk of major cardiovascular events - unlike other antibodies that target different aspects of the immune system, found researchers from the Perelman School of Medicine at the University of Pennsylvania, in collaboration with the National Heart, Lung, and Blood Institute (NHLBI)....

... / ... Lire la suite

Drug to Treat Daytime Sleepiness Does Not Improve Driving Task Performance  Voir?

Armodafinil, drug used to treat daytime sleepiness does not appear to improve driving in those with sleep apnea, revealed researchers. Nor did those taking the drug report less daytime sleepiness than those receiving a placebo, as measured by the Epworth Sleepiness Scale and the Functional Outcomes of Sleep Questionnaire. In the study, 113 participants (ages 18 to 70) were randomly assigned to either receive 150 mg of armodafinil daily or a placebo. Participants had moderate to severe OSA, were ...

... / ... Lire la suite

Early-onset Cannabis Use May Increase Drug Abuse Problems in Later Life  Voir?

Cannabis use at an early age may lead to drug abuse problems in later life, reveals a new study. What a difference a year or two can make: If you started smoking marijuana at the start of your teens, your risk of having a drug abuse problem by age 28 is 68 percent, but if you started smoking between 15 and 17 your risk drops to 44 percent, according to a new study by Universite de Montreal researchers. All the more reason, they say, to educate kids early, in primary school, about the risks of ...

... / ... Lire la suite

Diabetes Drugs Can Treat Alzheimer's Disease  Voir?

Diabetes drugs can be used effectively in the treatment of Alzheimer's disease. Understanding the pathway that links Alzheimer's disease and Type 2 diabetes can lead to the development of new therapeutic strategies to preserve brain health, reports a new study. Fernanda De Felice at Queen's University has discovered a disease mechanism common to Alzheimer's disease and Type 2 Diabetes. This mechanism, which consists of a pathway leading to inflammation in different parts of the brain, leads to ...

... / ... Lire la suite

Recurrent Strokes Could be Prevented With Drug Combination  Voir?

To suffer a stroke can be a life-changing event, scarring the patient with permanent effects and higher risks of a recurring stroke attack. Combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms lowers the risk of a new stroke, heart attack or other ischemic event within 90 days, say researchers. This international clinical trial of more than 4880 participants, was published in the iNew England Journal of Medicine/i. The combination therapy was also ...

... / ... Lire la suite

Imaging Pill to Diagnose Breast Cancer  Voir?

New non-invasive "disease screening pill" that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation developed by scientists. Findings of the study reported in ACS' journal Molecular Pharmaceutics. Breast cancer is the second most common cancer in women, according to the American Cancer Society. Mammograms are X-rays of breast tissue that can provide information about a lump's location and size, but they can't distinguish between cancerous and benign growths....

... / ... Lire la suite

Rheumatoid Arthritis Drugs Taken During Pregnancy Not Linked to Serious Infection Risk in Child  Voir?

When pregnant women take certain rheumatoid arthritis (RA) drugs that may cause immunosuppression, a study found their children do not have a marked excess risk of developing serious infections. The iArthritis (and) Rheumatology /ifindings are potentially encouraging for women with RA who are or wish to become pregnant. In North America, infections are the leading cause of mortality in children less than 5 years. There are concerns that tumor necrosis factor inhibitors (TNFis), which are used to ...

... / ... Lire la suite

Drug Used to Treat Bleeding can Now Treat Brain Stroke  Voir?

A drug used to treat blood loss from major trauma and bleeding after childbirth can help treat patients with a stroke caused by bleeding in the brain (intracerebral hemorrhage), reveals an international trial. The study, led by experts at The University of Nottingham and funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme, found that giving btranexamic acid (TXA)/b to people who had experienced intracerebral haemorrhage reduced the number of deaths in the early days following the stroke....

... / ... Lire la suite

Stroke Prevented by Acute Intervention of Antiplatelet Drug Combination  Voir?

bHighlights:/b ul class="group-list"liPatients given clopidogrel along with aspirin after experiencing either a transient ischemic attack (TIA) or a minor stroke show a lowered risk of getting a major stroke within ninety days after the first incident/liliBleeding episodes, mostly gastrointestinal occurred in a small percentage of the patients but were reversible and none fatal/liliOverall benefits of preventing a major disabling stroke are far greater with the drug combination, ...

... / ... Lire la suite

Potential Drug Targets for Cancer Uncovered  Voir?

Up to 100 new potential targets were uncovered using mass spectrometry based proteomics. These proteins could play a critical role propagating signals within cells that can lead to uncontrolled cell growth - one of the hallmarks of cancer, revealed Protein researchers from the Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen. mass spectrometry based proteomics to uncover a number of proteins which could play a critical role propagating signals within cells ...

... / ... Lire la suite

New Drug Shows Preclinical Efficacy in Rett Syndrome  Voir?

New study shows how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome in preclinical models. The study published in the Cell Reports, led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics of the University of Barcelona, and Dr. Sonia Guil, researcher at the same IDIBELL group, has been possible thanks ...

... / ... Lire la suite

Dernière mise à jour : 20/06/2018 @ 02:47

cadeau.gifSpécial !


 Le Centre National de Toxicologie et La Société Algérienne de Toxicologie ont le plaisir d’annoncer la tenue des  8èmes Journées de Toxicologie qui se dérouleront les 18 et 19 Novembre 2015 à Constantine


Images du Jour



Se reconnecter

Votre nom (ou pseudo) :

Votre code secret

 Nombre de membres 1235 membres

Connectés :

( personne )


   visiteurs en ligne

Webmaster - Infos
W3C CSSLicence Creative CommonsSATOX BENDJI
^ Haut ^